Patently Strategic - Patent Strategy for Startups
Podcast autorstwa Aurora Patent Consulting | Ashley Sloat, Ph.D.
43 Odcinki
-
ParkerVision v. Rule 36: The Battle for Dignity and Due Process
Opublikowany: 17.03.2025 -
Dealing with Rejection: Overcoming 101, 102, 103, and 112
Opublikowany: 6.02.2025 -
Patent Case Law Review: Obviousness
Opublikowany: 6.12.2024 -
Petition Practice: Correcting PTO Errors With Your Patent
Opublikowany: 5.11.2024 -
Keeping Patent Pirates at Bay: ITC Portfolio Proofing Strategies
Opublikowany: 1.10.2024 -
Continuation Practice: Quality Patents Part 3
Opublikowany: 6.09.2024 -
PTAB Survival Guide: Quality Patents Part 2
Opublikowany: 1.08.2024 -
Quality Patents
Opublikowany: 2.07.2024 -
Inventor Stories: Robert Cameron and the Power of Perseverance
Opublikowany: 3.06.2024 -
CAFC Chronicles: Costly Tales of Claim Construction Fails
Opublikowany: 1.05.2024 -
Patents and AI: Current Tools, Future Solutions
Opublikowany: 20.03.2024 -
James Howard and the Black Inventors Hall of Fame
Opublikowany: 22.02.2024 -
Claim Construction: Building Strong Patent Foundations
Opublikowany: 31.01.2024 -
Patenting Games: From Pieces to Pixels
Opublikowany: 24.11.2023 -
Patent Claims: The Name of the Game
Opublikowany: 6.10.2023 -
Government Grants and Patent Rights: SBIR, STTR, and Your IP
Opublikowany: 6.09.2023 -
Jack Daniels, Mickey Mouse, and Andy Warhol Walk Into a Bar
Opublikowany: 27.07.2023 -
Why Patents Exist with Professor Adam Mossoff
Opublikowany: 27.06.2023 -
What Investors Want in Patents with Sridhar Iyengar
Opublikowany: 30.05.2023 -
Open Source and Patent Rights: Collaboration with Consequences
Opublikowany: 27.04.2023
A patent focused podcast for inventors, founders, and IP professionals, covering the finer points, sharp edges, and nuances of startup patent strategy. Each monthly episode will feature a round-table style discussion amongst experts in the field of patenting. Patently Strategic is brought to you by Aurora Consulting, a patent strategy boutique that specializes in working with early stage life science, medical device, digital health, and software companies to develop valuable patent portfolios through highly tailored, comprehensive strategies.
